no more tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL FDA Announces End To Compounded

Although I have only 1 injection under my belt, I believe this to be the utmost pharmaceutical grade Zepbound needed for my weightloss goals

The program is specifically intended to support patients using the medication as approved by the FDA

Tesamorelin Peptide Therapy: Understanding Its Distinct Role Tesamorelin operates as a potent tool for tackling excess abdominal fat , particularly in individuals with HIV-associated lipodystrophy

The American Diabetes Association provides general recommendations for alcohol consumption in diabetes that apply to patients on tirzepatide, with some additional considerations specific to GLP-1 receptor agonist therapy